NHS Diabetes Prevention Programme
Public Health England and Diabetes UK, NHS England wishes to procure a Framework Agreement with up to 4 (four) providers who are able to provide, anywhere in England, between 10 000 and 100 000 behavioural interventions aimed at preventing or delaying the onset of Type 2 diabetes.
United Kingdom-Leeds: Health and social work services
Section I: Contracting authority
I.1)Name, addresses and contact point(s)
National Health Service Commissioning Board
Quarry House, Quarry Hill
For the attention of: Dosanjh Raj
LS2 7UE Leeds
General address of the contracting authority: http://www.ardengemcsu.nhs.uk/
Address of the buyer profile: https://www.england.nhs.uk/
Electronic access to information: https://ardengemcsu.bravosolution.co.uk/web/login.html
Electronic submission of tenders and requests to participate: https://ardengemcsu.bravosolution.co.uk/web/login.html
Further information can be obtained from: The above mentioned contact point(s)
Specifications and additional documents (including documents for competitive dialogue and a dynamic purchasing system) can be obtained from: The above mentioned contact point(s)
Tenders or requests to participate must be sent to: The above mentioned contact point(s)
I.2)Type of the contracting authority
I.4)Contract award on behalf of other contracting authorities
The contracting authority is purchasing on behalf of other contracting authorities: yes
National Health Service Commissioning
Quarry House, Quarry Hill
LS2 7UE Leeds
Section II: Object of the contract
II.1.1)Title attributed to the contract by the contracting authority:
II.1.2)Type of contract and location of works, place of delivery or of performance
Service category No 25: Health and social services
Main site or location of works, place of delivery or of performance: United Kingdom.
NUTS code UK
II.1.3)Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
II.1.4)Information on framework agreement
Framework agreement with several operators
Duration of the framework agreement
Duration in months: 36
Estimated total value of purchases for the entire duration of the framework agreement
Estimated value excluding VAT:
Range: between 3 000 000 and 116 000 000 GBP
II.1.5)Short description of the contract or purchase(s)
The primary aim of the NDPP is to reduce the incidence of Type 2 diabetes in the cohort referred onto the NDPP (i.e. those with non-diabetic hyperglycaemia). The secondary aims are:
(i) to reduce blood glucose parameters (Hba1c or Fasting Plasma Glucose) in participants at 12 months and beyond;
(ii) to reduce weight of participants at 12 months and beyond, and
(iii) to maximise programme completion rates by those referred onto the programme. A tertiary aim of the programme is to establish sound data collection mechanisms to ensure that programme effectiveness to reduce the long term microvascular and cardiovascular complications of Type 2 diabetes, as well as to reduce the associated higher mortality risk, can be assessed.
The behavioural interventions should include a focus on diabetes risk, weight loss, physical activity and diet and explicit use of behavioural theory and strategies. The focus is on individuals who are on the threshold of developing diabetes and non-diabetic hyperglycaemia is defined as having an HbA1c 42 — 47 mmol/mol (6.0 — 6.4 %) or a fasting plasma glucose (FPG) of 5.5 — 6.9 mmol/mol. Only individuals aged 18 years or over will be eligible for the behavioural intervention and the primary routes of referral will be by a General Practitioner or via the NHS Health Check and a blood test must have been completed prior to referral. Successful providers may be able to seek potential service users using a direct to consumer approach. Further details will be set out in the Invitation to Tender (ITT). NHS England will seek to identify Clinical Commissioning Groups and Local Authorities with which it might enter into separate arrangements in relation to referrals. It is anticipated that Clinical Commissioning Groups and/ or Local Authorities will be involved in awarding contracts under the Framework Agreement and the contracts may be awarded by way of a direct call off or following a reopening of competition. Interested providers must be able to deliver the behavioural interventions anywhere in England and the ability to mobilise quickly may be assessed at tender stage. Further details will be set out in the ITT.
The results of the behavioural interventions will be evaluated to inform any potential changes to the specification during the term of the Framework Agreement. NHS England therefore reserves the right to make non material amendments to the specification during the term of the Framework Agreement to improve the behavioural interventions, however NHS England may also carry out further procurement processes in relation to the NDPP. Providers may deliver aspects of the behavioural interventions through innovative means (such as, but not limited to, via the internet or a mobile phone application) however the core requirement in the specification will be that the behavioural interventions will be delivered face to face because evidence from previous diabetes prevention programmes sets out that face to face services are more likely to lead to a successful outcome for the service user. Where innovative means are used for the delivery of the behavioural interventions, they would have to be the subject of an evaluation and the data on outcomes would have to be shared with, and the relevant provider would have to work with, the relevant evaluation team in relation to that evaluation.
During the first year of the Framework Agreement, it is anticipated that providers would be paid on a per intervention basis. NHS England reserves the right to vary the Framework Agreement during its term so that the payment mechanism is amended to reflect a payment by results (often referred to as outcomes based) mechanism. Further details will be set out in the ITT.
II.1.6)Common procurement vocabulary (CPV)
85000000, 85140000, 85312310, 98000000, 85141000, 85312320, 85322000, 80000000, 85312300, 98336000, 75200000, 98334000, 85323000,85100000
II.1.7)Information about Government Procurement Agreement (GPA)
II.1.9)Information about variants
II.2.1)Total quantity or scope:
II.2.2)Information about options
Description of these options: The Framework Agreement will include the option for the Contracting Authority to extend it for a further 12 months in addition to the initial 36 months period upon review.
II.2.3)Information about renewals
II.3)Duration of the contract or time limit for completion
Section III: Legal, economic, financial and technical information
III.1.1)Deposits and guarantees required:
III.1.2)Main financing conditions and payment arrangements and/or reference to the relevant provisions governing them:
III.1.3)Legal form to be taken by the group of economic operators to whom the contract is to be awarded:
III.1.4)Other particular conditions
III.2.1)Personal situation of economic operators, including requirements relating to enrolment on professional or trade registers
III.2.2)Economic and financial ability
These will be set out in the Pre-Qualification Questionnaire.
Section IV: Procedure
IV.1.1)Type of procedure
IV.1.2)Limitations on the number of operators who will be invited to tender or to participate
Objective criteria for choosing the limited number of candidates: This is set out in the Pre Qualification Questionnaire.
IV.2.2)Information about electronic auction
IV.3.2)Previous publication(s) concerning the same contract
Prior information notice
Notice number in the OJEU: 2015/S 54-094568 of 18.3.2015
IV.3.3)Conditions for obtaining specifications and additional documents or descriptive document
IV.3.4)Time limit for receipt of tenders or requests to participate
IV.3.6)Language(s) in which tenders or requests to participate may be drawn up
Section VI: Complementary information
VI.1)Information about recurrence
VI.2)Information about European Union funds
Before the award of the Framework Agreement, successful providers will have to have in place Cyber Essentials Basic certification or equivalent. During the first year of the Framework Agreement, the successful providers will be contractually obliged to obtain Cyber Essentials Plus certification or equivalent. Any organisation interested in providing the Services should following the details below:
The PQQ reference for this procurement is: pqq_169.
To register on the portal: https://ardengemcsu.bravosolution.co.uk/web/login.html
— From the Home Page, click the ‘Click Here to Register’ link.
— Accept the terms and conditions for using the portal.
— Complete your organisation & personal details.
— Choose a memorable username and submit.
You will shortly be sent an email with your unique password, please treat this securely (if you lose it there is a ‘Forgot my Password’ link on the portal homepage).
To Access the portal:
— Login with your unique username and password.
— From the suppliers reserved area click ‘PQQ’s Open to All Suppliers’ –this is a repository of all PQQ’s open to any registered supplier.
— Browse the PQQ’s (there may be more than one page) and select ‘NHS Diabetes Prevention Programme Phase 1’ by clicking on it.
— Note the Details buttons on the left for Navigation and the Actions below.
— Click the ‘Express Interest’ action –this will move the PQQ from the PQQ’s Open to All Suppliers area to your ‘My PQQ’s’ area –this is a reserved area for PQQs that you have either been invited to or expressed interest in.
For Bravo technical issues, please contact +44 8003684850 or firstname.lastname@example.org
The deadline for organisations to submit their completed PQQ responses will be the date in section IV.3.4.
This Contract Notice is a voluntary notice. The reference to ‘restricted procedure’ at section IV.1.1 does not apply. The Contracting Authority therefore reserves the right to have negotiation and/or dialogue with Bidders if required and further details will be set out in the ITT. The procurement will be run in accordance with Regulation 5(2) of the Public Contracts Regulations 2006 (the ‘Regulations’) that sets out specific Regulations that apply to contracts for Part B services. The Contracting Authority will not be bound by the Regulations except to the extent that they specifically apply to Part B services contracts.
At tender stage the Contracting Authority reserves the right to introduce financial envelopes within which the services must be priced. Further details (if required) regarding these requirements will be detailed in the tender documents. NHS England does not anticipate that the Transfer of Undertakings (Protection of Employment) Regulations 2006 (‘TUPE’) will apply in locations where this is to be a novel service. However, bidders should make their own enquiries as to the extent that similar existing services are provided locally. On expiry of the services provided under the contracts resulting from this procurement process, it is envisaged that the services will be reprocured and that TUPE will apply where any new bidder takes over substantially the same service. Bidders will be expected to comply with an orderly transition to the new provider.
Tenders and all supporting documentation for the contracts must be priced in sterling and written in English. Any agreements entered into will be governed by English Law and will be subject to the exclusive jurisdiction of the English Courts.
The Contracting Authority is not liable for any costs, charges or expenses incurred by candidates or tenderers in bidding for this contract opportunity.
The Contracting Authority reserves the right to cancel this tender process at any time and not to award any of the contracts/ any part of the contracts.
VI.4.2)Lodging of appeals
VI.5)Date of dispatch of this notice: